Cardiogenic Shock From Chronic Immune Checkpoint Inhibitor Associated Myocarditis Causing Predominant Right Ventricular Failure

By afschroeder • March 31, 2026

Sekhon H, Rajendran PS, Hampilos K, Raddatz MA, Lilley CM, Zinoviev RI, Tai W, Stein-Merlob AF, Fishbein GA, Yang EH. Cardiogenic Shock From Chronic Immune Checkpoint Inhibitor Associated Myocarditis Causing Predominant Right Ventricular Failure. JACC CardioOncol. 2026 Mar 28:S2666-0873(26)00063-3. doi: 10.1016/j.jaccao.2026.03.005. Epub ahead of print. PMID: 41910517.

Tags: cardio-oncology, cardiogenic shock, Cardiology/Epi, Fellow, General Internal Medicine, immune checkpoint inhibitor, Myocarditis, Publications, Resident, right ventricle

A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

Wazni OM, Chun KJ, Amin A, Anic A, Ajijola OA, Gibson DN, Mansour M, Makati K, Chrispin J, Duytschaever M, Nair DG, Piccini JP, Natale[...]

Cardiac Myxoma With Atypical Presentation Leading to Delayed Diagnosis: A Case Report

Alishala M, Trinh T, Lee JS. Cardiac Myxoma With Atypical Presentation Leading to Delayed Diagnosis: A Case Report. Cureus. 2026 Feb 26;18(2):e104308. doi: 10.7759/cureus.104308. PMID:[...]

Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study

Marston NA, Bergmark BA, Prohaska TA, Moura FA, Zimerman A, Alexander VJ, Kang YM, Weinland J, Ran X, Murphy SA, Zhang S, Li D, Banach[...]